M3 lands ex-Epocrates research head, others

Share this article:
Heather Gervais
Heather Gervais

Athenahealth has wasted little time in putting its mark on Epocrates.

The electronic health records and practice management giant had barely finalized February's $293-million, all-cash acquisition of mobile health firm Epocrates, when it eliminated part of the mobile health firm's market research business which offered other marketing research firms access to its physician panels.

Eight of those employees were hired by MDLinx owner M3 Global Research, an Epocrates partner. The hires included former Epocrates market research lead Sheryl Lowenhar.

“We've been taking a look at all of our initiatives to see what fits strategically,” said Heather Gervais, SVP commercial operations at Epocrates. “At its center, that's helping caregivers make good decisions, and we decided that being a broker didn't meet our needs.”

Gone is the company's QuickRecruit business, whereby research firms doing surveys could buy access to Epocrates' physician panels. The company will keep its insight analytical platform, which caters to Wall Street analysts seeking market insights and to pharmas wanting basic message testing and segmentation in a hurry.

Epocrates will continue to honor existing QuickRecruit contracts, said Gervais, but won't take on new clients for it.

Ex-Epocrates manager Lowenhar will now head up M3 strategic client accounts and report to Roni DasGupta, head of client accounts, according to a statement.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?